О семинаре "Генная терапия и редактирование генома с помощью CRISPR-Cas9: подходы и решения"

16 апреля 2018 года в ФГБУ "НИИ гриппа" Минздрава России состоялся семинар "Генная терапия и редактирование генома с помощью CRISPR-Cas9: подходы и решения" (Gene therapy and genome editing using CRISPR-Cas9: approaches and solutions) с участием представителей Бостонского и Вашингтонского университетов. 

В ходе семинара были заслушены следующие доклады: 

• Cellular Mechanisms that Establish and Maintain HIV Latency 

  Andrew J. Henderson, PhD

  Assistant Dean Graduate Medical Sciences, Department of Medicine and Microbiology, Section of Infectious Diseases, Boston University School of Medicine, USA
• AAV-mediated delivery of CRISPR/Cas9 and related nucleases for cure of persistent viral infections
  Keith R. Jerome, MD, PhD
  Member, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Professor and Head, Virology Division, Department of Laboratory Medicine, University of Washington, USA
• Microcapsules as universal biocompatible platform for intracellular delivery of coding/noncoding nucleic acids
  Aleksander Timin 

  Timin A.S.^1,2, Brodskaya A.V.^2,3, Muslimov A.R.^3,4, Sukharukov G.B.^1,2,5, Vasin A.V.^2,3

  ¹RASA center in Tomsk, Tomsk Polytechnic University, Tomsk, Russia

  ²Peter the Great St. Petersburg Polytechnic University, Saint-Petersburg, Russia

  ³Research Institute of Influenza, Saint-Petersburg, Russia 

  ⁴Pavlov First Saint Petersburg State Medical University, Saint-Petersburg, Russia, 

  ⁵School of Engineering and Materials Science, Queen Mary University of London, United Kingdom
• Hematological malignancies in HIV-patients: from stem cell transplantation to gene therapy

  Boris Afanasyev, MD, PhD 

  Professor, Director of Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation at the First I. Pavlov State Medical University, St. Petersburg

  Marina Popova, MD, PhD, hematologist, associate professor, Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation at the First I. Pavlov State Medical University, St. Petersburg
• CCR5 gene editing in hematopoietic stem cells by CCR5-Uco-TALEN

  Alena Shakirova, MS

  Molecular biologist, Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation at the First I. Pavlov State Medical University, St. Petersburg